Caratterizzazione molecolare e funzionale di cellule staminali ematopoietiche di Ematopoiesi Clonale dal Potenziale Indeterminato

Title

Code

CHIPBone

Type

Sperimentale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366216

dante.dallari@ior.it

Dallari Dante, MD

Director

Reconstructive Orthopaedic Surgery Innovative Techniques - Musculoskeletal Tissue Bank

Operational unit that carry out the study

complex unit

Chirurgia Ortopedica Ricostruttiva Tecniche Innovative - Banca del Tessuto Muscoloscheletrico (BTM)

Director

Dallari Dante, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. CHIPBone

Monday 18 March 2024, 13:49

PG0004320_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Caratterizzazione molecolare e funzionale di cellule staminali ematopoietiche di Ematopoiesi Clonale dal Potenziale Indeterminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Caratterizzazione molecolare e funzionale di cellule staminali ematopoietiche di Ematopoiesi Clonale dal Potenziale Indeterminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in